A new report from ProgenyHealth highlights the importance of taking a multipronged approach to identifying and managing risk factors for maternal health and taking steps to reduce the risks of premature births.
Tia Health recently launched its longevity service line, which is starting with a focus on heart health. It includes labs and one-on-one provider guidance.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma.
In this episode, we’re joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report.
Monarch, which launched Tuesday, provides the support and technology to help women's health providers create their own independent practices.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
In this episode, we’re joined by Margaret Malone, principal of Flare Capital Partners. She discusses the investment trends she’s following in the women’s health space and advice she has for startups.
The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health.
Women's Health Access Matters recently launched the Innovator's Circle, which brings together leaders from women’s health-focused funds, including Amboy Street Ventures, Emmeline Ventures and March of Dimes.
Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect musculoskeletal and metabolic health for lifelong strength and well-being.
Break down the silos. Take control of your provider data.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care.
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California.
Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated norms, we are beginning to see improvement. Still, there’s much more work to be done.
Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives.
Cofertility raised $7.25 million in Series A funds, taking its total funding to date to $16 million. The startup is making egg freezing more accessible by tying it to egg donation — it offers one program in which women can pay to freeze their eggs and store them all for their own later use, and another one that allows women to freeze their eggs for free when they give half to a family who can’t otherwise conceive.